The present study included data from three marathon races to investigate th
e hypothesis that a relationship exists between running intensity and eleva
ted concentrations of interleukin (IL)-6 in plasma. The study included a to
tal of 53 subjects whose mean age was 30.6 [95% confidence interval (CI) 1.
4] years, mean body (95%CI 2.0) kg, mean maximal oxygen uptake ((V) over do
t O-2max) 59.3 (95%CI 1.4) ml(.)min(-1.)kg(-1), and who had participated in
the Copenhagen Marathons of 1996, 1997 or 1998, achieving a mean running t
ime of 206 (95%CI 7) min. Running intensity was calculated as running speed
divided by (V) over dot O-2max. The concentration of IL-6 in plasma peaked
immediately after the run. There was a negative correlation between peak I
L-6 concentration and running time (r = -0.30, P < 0.05) and a positive cor
relation between peak IL-6 concentration and running intensity (r = 0.32, P
< 0.05). The IL-1 receptor antagonist (IL-1ra) plasma concentration peaked
1.5 h after the run and there was a positive correlation between the peak
plasma concentrations of IL-6 and IL-1ra (r = 0.39, P < 0.01). Creatine kin
ase (CK) plasma concentration peaked on the Ist day after the run, but no a
ssociation was found between peak concentrations of IL-6 and CK. In conclus
ion, the results confirmed the hypothesized association between plasma IL-6
concentration and running intensity, but did not confirm the previous find
ing of a connection between IL-6 plasma concentration and muscle damage.